INREF InRetail Perú (PNK) $26.84 market hours 11 Feb 2026: oversold bounce to $32.62

INREF stock trades at $26.84 on the PNK exchange in market hours on 11 Feb 2026, setting up a short-term oversold bounce opportunity. The share price sits near its year low of $26.84 while the 200-day average is $27.37, suggesting recent selling pressure. Volume is light at 1,550 shares but relative volume is elevated at 2.15, signaling buyer interest. With a trailing PE of 10.36 and EPS of 2.59, this retail group merits a tactical trade idea focused on a measured bounce toward our monthly model target of $32.62.

INREF stock: current quote and quick facts

INREF InRetail Perú Corp. (PNK) is quoted at $26.84 USD with market cap about $2.85B and shares outstanding 106,256,142. Key fundamentals include EPS 2.59, PE 10.36, and dividend per share 2.01 with a yield near 2.23%. Trading volume today is 1,550 versus average 722, and the 50-day average is $26.84 while the 200-day average is $27.37.

Why this is an oversold bounce setup for INREF stock

Price sits at the lower bound of its one-year range ($26.84) and under the 200-day average, a common technical context for a bounce trade. The stock is down 7.88% over 12 months and down 25.46% over three years, creating mean-reversion potential. Relative volume of 2.15 suggests higher attention; traders can treat this as a tactical oversold bounce rather than a long-term reversal.

Fundamental snapshot and valuation context for INREF stock

InRetail Perú operates supermarkets, pharmacies, distribution, shopping centers and digital commerce in Peru. Valuation metrics show price to sales 0.43, price to book 1.51, EV/EBITDA 7.28, and free cash flow yield 19.58%, reflecting cash-generative retail operations. Debt to equity is elevated at 1.46, and current ratio 0.86 signals working capital pressure; these fundamentals support caution while leaving room for an earnings-driven bounce.

Technical levels, trade plan and risk controls for INREF stock

Short-term support is the year low at $26.84 and resistance sits near the 200-day average $27.37 and the recent high $29.13. A tactical trade: buy a partial position between $26.50–$26.90, target $32.62 (monthly model), stop $25.50 to limit downside. Use position sizing to limit portfolio risk to 1–2% and watch volume confirmation above 3,000 shares for sustained follow-through.

Catalysts, earnings timing and sector context for INREF stock

Earnings are scheduled for 27 Feb 2026, a near-term catalyst that can validate the bounce or trigger renewed selling. The consumer cyclical sector in Peru benefits from improving consumption trends, but mall leasing and COVID-era recovery remain variables for the shopping center segment. Monitor Inkafarma pharmacy sales and digital growth metrics as key drivers of next-quarter revenue and margin improvement.

Meyka AI grades and model forecasts for INREF stock

Meyka AI rates INREF with a score out of 100: 70.82 | Grade: B+ | Suggestion: BUY. This grade factors in S&P 500 and sector comparisons, financial growth, key metrics, forecasts and analyst signals. Meyka AI’s forecast model projects a monthly target of $32.62 and a yearly projection of $24.30, offering both a tactical upside case and a cautionary 12-month downside scenario. These model outputs are projections and not guarantees. For live charts visit the company site or our platform: InRetail website and FinancialModelingPrep INREF page.

Final Thoughts

Key takeaways for INREF stock: the shares trade at $26.84 on PNK with elevated relative volume and a short-term oversold profile that supports a bounce trade. Meyka AI’s model projects a monthly price target of $32.62, implying roughly 21.53% upside from the current price, while the yearly model sits at $24.30, implying -9.46% downside if momentum fades. Balance the upside case against a debt to equity of 1.46 and a sub‑1.0 current ratio, which increase the financial risk if consumer demand softens. For traders, a disciplined entry between $26.50–$26.90, stop at $25.50, and a staged exit into strength towards $32.62 is a measurable approach. Investors should treat this as an oversold bounce tactic, not proof of a durable turnaround. Meyka AI provides this as AI-powered market analysis and model-based projections; forecasts are model outputs, not guarantees.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.